Murkowski Urges FDA Nom. To Advance The 'Acceleration Approval Pathway’ For Rare Disease Treatment

19 hours ago
65

3/06/2025

During Thursday’s Senate Health, Education, Labor, and Pension Committee hearing, Sen. Lisa. Murkowski (R-AK) questioned Trump’s FDA Commissioner Nominee Martin Makary about ALS treatment and the FDA acceleration approval pathway for the treatments to rare diseases.

Loading comments...